DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 55 · September 2022 DOI: 10.1055/s-012-55046

Review

  • 233
    Lopez-Morinigo, Javier-David; Leucht, Stefan; Arango, Celso:

    Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs

    Open Access

    • Original Paper

  • 246
    Scherf-Clavel, Maike; Weber, Heike; Wurst, Catherina; Stonawski, Saskia; Hommers, Leif; Unterecker, Stefan; Wolf, Christiane; Domschke, Katharina; Rost, Nicolas; Brückl, Tanja; Lucae, Susanne; Uhr, Manfred; Binder, Elisabeth B.; Menke, Andreas; Deckert, Jürgen:

    Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response

    Open Access
    Supplementary Material (PDF)
  • 255
    Egberts, Karin M.; Gerlach, Manfred; Correll, Christoph U.; Plener, Paul L.; Malzahn, Uwe; Heuschmann, Peter; Unterecker, Stefan; Scherf-Clavel, Maike; Rock, Hans; Antony, Gisela; Briegel, Wolfgang; Fleischhaker, Christian; Häge, Alexander; Hellenschmidt, Tobias; Imgart, Harmut; Kaess, Michael; Karwautz, Andreas; Kölch, Michael; Reitzle, Karl; Renner, Tobias; Reuter-Dang, Su-Yin; Rexroth, Christian; Schulte-Körne, Gerd; Theisen, Frank M.; Walitza, Susanne; Wewetzer, Christoph; Fekete, Stefanie; Taurines, Regina; Romanos, Marcel:

    Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice

    Open Access
  • 266
    Esen-Sehir, Dilhan; Kopf, Juliane; Hägele, Sandra; Plichta, Michael M.; Reif, Andreas; Freudenberg, Florian:

    Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia

    Supplementary Material (PDF)

    • Letter to the Editor

  • 274
    Colijn, Mark A.:

    The Therapeutic Potential of Pimavanserin in the Treatment of Hallucinogen Induced Psychosis and Persistent Perceptual Symptoms